tert-Butylisocyanate

tert-Butylisocyanate Structure
tert-Butylisocyanate structure
Common Name tert-Butylisocyanate
CAS Number 1609-86-5 Molecular Weight 99.13110
Density 0.868 g/mL at 25 °C(lit.) Boiling Point 85-86 °C(lit.)
Molecular Formula C5H9NO Melting Point <-25ºC
MSDS Chinese USA Flash Point 24 °F
Symbol GHS02 GHS05 GHS06 GHS08
GHS02, GHS05, GHS06, GHS08
Signal Word Danger

Synthesis and structural characterization of a terminal hydroxide containing alumoxane via hydrolysis of aluminum hydrides.

Inorg. Chem. 43(4) , 1217-9, (2004)

A novel terminal hydroxide containing dinuclear alumoxane LAl(OH)OAlL(OCH=N-tBu) (3; L = HC(CMeNAr)2, Ar = 2,6-iPr2C6H3) was prepared by treatment of aluminum dihydride LAlH2 (1) and tert-butyl isocyanate in the presence of trace amounts of water and alternat...

Molybdenum oxo-imido aryloxide complexes: oxo analogues of olefin metathesis catalysts.

Inorg. Chem. 45(11) , 4556-61, (2006)

The novel 16-electron molybdenum oxo-imido bis(aryloxide) complexes [Mo(NtBu)(O)(2,6-Me2C6H3O)2(py)] (1) and [Mo(NtBu)(O)(2,6-iPr2C6H3O)2(py)] (2) have been prepared by the salt elimination reactions of [Mo(NtBu)(O)Cl2(DME)] with the appropriate lithium arylo...

Versatile stereoselective cycloadditions between heterocumulenes and phosphagermaallene Tip(tBu)Ge=C=PMes*: experimental and theoretical investigations.

Chemistry 17(45) , 12763-72, (2011)

Phosphagermaallene Tip(tBu)Ge=C=PMes* 1 (Tip=2,4,6-triisopropylphenyl, Mes*=2,4,6-tri-tert-butylphenyl) reacts with phenyl isocyanate and tert-butyl isocyanate by a [2+2] cycloaddition that involves the Ge=C and C=O double bonds to afford 1-oxa-2-germacyclobu...

Inhibition of carcinogen-induced neoplasia by sodium cyanate, tert-butyl isocyanate, and benzyl isothiocyanate administered subsequent to carcinogen exposure.

Cancer Res. 41(8) , 2991-4, (1981)

The effects of sodium cyanate, tert-butyl isocyanate, and benzyl isothiocyanate on carcinogen-induced neoplasia were studied in experiments in which the test compound was fed starting 1 week following completion of carcinogen administrations. Under these cond...